The fourth instalment of the LTR Pharma Conversation Series is now live. 

This week, Professor Chung shares insights into nasal delivery technology and why it is an effective pathway to treat erectile dysfunction; clinical evidence to support the benefits and mechanism of action of SPONTAN®; and why patients are interested in this new treatment. 

For more information, please click here: